Jin Lee

Jin Lee, PhD, currently serves as a Research Analyst at Point72 since December 2021, with a focus on biotech equity research. Prior experience includes working as an Equity Research Associate at BMO Capital Markets from January 2020 to November 2021 and interning in biotech equity research at Wolfe Research, LLC in late 2018. Jin Lee completed a PhD in Molecular Biology at Weill Cornell Medicine, where studies took place from January 2015 to December 2019. Education also includes a Bachelor's degree in Molecular Biology from Cornell University and successfully passing CFA Level II in 2019 through the CFA Institute.